JPM vs RCAT Stock Comparison
JPM currently leads RCAT in this stock comparison, with AIQ scores of 53 vs 34. The clearest difference is momentum.
What is the main difference between JPM and RCAT?
JPM leads the current stock comparison as JPMorgan Chase & Co., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
JPMorgan Chase & Co. vs Red Cat Holdings, Inc.
JPM leads
JPM leads by 19 AIQ points, primarily on Momentum and Risk Resilience, and the lead has widened from 10 points over 30 sessions. Wall Street currently favors RCAT on target upside.
Stable: 5 of 6 evidence groups support JPM, its lead is widening, and its current signal state is conflicted.
JPMorgan Chase & Co.
Red Cat Holdings, Inc.
The Algovestiq AIQ Score currently favors JPM over RCAT, 53 versus 34 as of Oct 31, 2026. JPM's advantage is driven primarily by stronger momentum and risk resilience. JPM also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors RCAT. 5 of 6 covered evidence groups favor JPM today, and the comparison is rated Stable on stability: the leader is throwing conflicting signals. JPM lead: Strengthening — the AIQ differential moved from 10 to 19 points over 30 sessions. JPM leads on all four AIQ factor dimensions. Value is itself one of those four, so a sweep is not explained by valuation alone — it deserves additional scrutiny for unmodeled catalysts, expectations or event risk.
Compare JPMorgan Chase & Co. and Red Cat Holdings, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare JPM and RCAT against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum61 vs 26JPM +35
- Risk Resilience69 vs 52JPM +17
- Quality46 vs 33JPM +13
- Value44 vs 34JPM +10
5 of 6 evidence groups favor JPM. JPM’s edge is concentrated in momentum and risk resilience.
What changed since the last close
Latest scored session 2026-10-28, compared against the prior scored session 2026-10-27.
Largest factor move: Momentum +2
New signals
- BB Upper Band Breach — bearish, volatility, short horizon
Largest factor move: Momentum +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 5 active signals are unchanged.
JPM's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — JPM and RCAT both carry a full feed there.
The central trade-off
JPM (JPMorgan Chase & Co.): the stronger current systematic profile, led by momentum and risk resilience.
RCAT (Red Cat Holdings, Inc.): the counter-case, on analyst expectations — but at materially higher volatility, 64.8% against 13%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
JPMJPM on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
RCATRCAT on combined revenue and EPS growth.
Value
JPMJPM on the peer-relative Value factor, by 10 points.
Momentum
JPMJPM on the Momentum factor, by 35 points.
Lower downside
JPMJPM on Risk Resilience, by 17 points.
Analyst upside
RCATRCAT on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors JPM, analyst targets favor RCAT. That disagreement is the most useful thing on this page.
| Measure | JPM | RCAT | Note |
|---|---|---|---|
| Implied upside to target | +10.7% | +217.7% | RCAT has more room |
| Target dispersion | +32.2% | +129.2% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 11 | 6 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
5 of 6 covered evidence groups favor JPM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | JPM | 53 vs 34 |
| Fundamentals | JPMon balance | revenue growth -7.6% vs 30.5%; EPS growth -27.6% vs -18.2%; TTM ROE 17.9% vs -35%; gross margin 63.2% vs 8.6%; operating margin 28.2% vs -161.1% — JPM takes 3 of 5 decided legs, not all of them |
| Valuation | JPM | Value 44 vs 34 |
| Technicals | JPM | Price vs 50-day -2% vs -32.6%; vs 200-day 5.2% vs -53.6% |
| Risk Resilience | JPM | Risk Resilience 69 vs 52 |
| Analyst expectations | RCAT | Target upside 10.7% vs 217.7% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of JPM and RCAT and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 19 points. (supports the conclusion holding)
- 5 of 6 covered evidence groups point the same way. (supports the conclusion holding)
- The leader's advantage has been widening. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on JPM.
How the comparison changed
120 daily snapshots · Jun 29 – Oct 28JPM lead: Strengthening — the AIQ differential moved from 10 to 19 points over 30 sessions.
- Today
- JPM +19
- 53 vs 34
- 7 sessions ago
- JPM +16
- 50 vs 34
- 30 sessions ago
- JPM +10
- 44 vs 34
- 90 sessions ago
- JPM +14
- 52 vs 38
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 1 bearish, conflicted
Only JPM
- Golden Cross Active — bullish, trend, long horizon (6.57%)
- BB Upper Band Breach — bearish, volatility, short horizon
1 bullish / 2 bearish / 2 neutral, conflicted
Only RCAT
- Bollinger Band Squeeze — neutral, volatility, short horizon
- Death Cross Active — bearish, trend, long horizon (53.91%)
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (7.36%)
- Downtrend Structure Active — bearish, trend, long horizon
Both carry 1 more signal that do not separate them: MACD Bullish Crossover.
JPM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -1.9%, AIQ +1 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -8.32%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1RCAT closes the Momentum gap — currently 35 points behind, the largest single contributor to JPM's edge.
- 2RCAT's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3JPM's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
JPM leads on balance| Metric | JPM | RCAT |
|---|---|---|
| Revenue growth (YoY) | -7.6% | 30.5% |
| EPS growth (YoY) | -27.6% | -18.2% |
| Gross margin | 63.2% | 8.6% |
| Operating margin | 28.2% | -161.1% |
| Return on equity (TTM) | 17.9% | -35% |
| Debt to equity | 3.32 | 0.05 |
Performance
JPM leads 5 of 6 windows| Metric | JPM | RCAT |
|---|---|---|
| 1 week (5 sessions) | 1.2% | 7.2% |
| 1 month (20 sessions) | 2.6% | -24% |
| 3 months (63 sessions) | -3.3% | -33.5% |
| 6 months (126 sessions) | 9.7% | -55.6% |
| Year to date | 5.3% | -38.1% |
| 1 year (252 sessions) | 12.9% | -56% |
Technicals
JPM has the stronger structure| Metric | JPM | RCAT |
|---|---|---|
| RSI (14) | 60.9 | 30.8 |
| ADX (14) | 15 | 52.4 |
| Price vs 50-day | -2% | -32.6% |
| Price vs 200-day | 5.2% | -53.6% |
| Volatility (1M, annualized) | 13% | 64.8% |
Risk
JPM is the more resilient| Metric | JPM | RCAT |
|---|---|---|
| Beta | 0.73 | 3.6 |
| Sharpe ratio | 0.41 | -0.29 |
| Sortino ratio | 0.56 | -0.57 |
| Max drawdown | -15.5% | -74.8% |
| Current drawdown | -7.1% | -71.7% |
| Annualized volatility | 22% | 105.6% |
| Value at risk (95%) | -2.4% | -9.3% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, JPM or RCAT?
On the Algovestiq AIQ Score, JPM is the stronger of the two as of Oct 31, 2026, scoring 53 against RCAT's 34. The edge comes from momentum and risk resilience. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is JPM or RCAT the better buy right now?
JPM carries the stronger systematic profile as of Oct 31, 2026, and the comparison is rated Stable — 5 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor JPM over RCAT?
The composite weights Quality, Value, Momentum and Risk Resilience. JPM leads Momentum by 35 points; JPM leads Risk Resilience by 17 points; JPM leads Quality by 13 points. JPM leads on all four AIQ factor dimensions. Value is itself one of those four, so the sweep is not explained by RCAT simply being cheaper — it warrants extra scrutiny for unmodeled catalysts, forward expectations or event risk the factors do not capture.
Which has more analyst upside, JPM or RCAT?
Analyst price targets imply +10.7% upside for JPM and +217.7% for RCAT, so the Street currently favors RCAT. That points the opposite way to the AIQ Score, which favors JPM. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, JPM or RCAT?
JPM is the better-valued of the two on the peer-relative Value factor. JPM on the peer-relative Value factor, by 10 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, JPM or RCAT?
RCAT on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, JPM or RCAT?
JPM on the Momentum factor, by 35 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, JPM or RCAT?
JPM is the more resilient of the two, so the other name carries the higher downside risk. JPM on Risk Resilience, by 17 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is JPM more profitable than RCAT?
JPM leads on the comparable margin measures — gross margin 63.2% vs 8.6%; operating margin 28.2% vs -161.1%; ttm roe 17.9% vs -35%.
Is JPM's lead over RCAT getting stronger or weaker?
JPM lead: Strengthening — the AIQ differential moved from 10 to 19 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-29 and 2026-10-28. The lead has not changed hands in that window.
What would change the JPM vs RCAT verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: RCAT closes the Momentum gap — currently 35 points behind, the largest single contributor to JPM's edge; RCAT's Death Cross Active resolves — a bearish trend rule currently active against it; JPM's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about JPM and RCAT?
JPM: 2 bullish / 1 bearish, conflicted. RCAT: 1 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on JPM is Golden Cross Active (bullish, long horizon). On RCAT it is Death Cross Active (bearish, long horizon).
Compare JPM and RCAT with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.